These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
634 related items for PubMed ID: 7859239
1. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system. González MA, Straughan AB. Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239 [Abstract] [Full Text] [Related]
2. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system. González MA, Kisicki J, Straughn AB. Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257 [Abstract] [Full Text] [Related]
3. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur). Oosterhuis B, Brannan MD, Groen H, Peeters PA, Hempenius J, Radwanski E, Nomeir AA, Affrime MB, Jonkman JH. Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380 [Abstract] [Full Text] [Related]
4. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets. Gai MN, Isla A, Andonaegui MT, Thielemann AM, Seitz C. Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715 [Abstract] [Full Text] [Related]
5. Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I. Ohmori N, Inotsume N, Matsukura M, Higashi A, Iwaoku R, Tobino Y, Nakano M, Matsuda I. Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):148-52. PubMed ID: 3699941 [Abstract] [Full Text] [Related]
6. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA. Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [Abstract] [Full Text] [Related]
7. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects. Henney HR, Shah J. Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289 [Abstract] [Full Text] [Related]
8. Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium. Rojanasthien N, Kovjiriyapan K, Manorot M, Pothirat C. Asian Pac J Allergy Immunol; 2001 Jun; 19(2):69-78. PubMed ID: 11699723 [Abstract] [Full Text] [Related]
9. Influence of food on the rate and extent of absorption of theophylline after single dose oral administration of a controlled release tablet. Lagas M, Jonkman JH. Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):424-6. PubMed ID: 4044074 [Abstract] [Full Text] [Related]
10. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease. Tompson DJ, Vearer D. Clin Ther; 2007 Dec; 29(12):2654-66. PubMed ID: 18201581 [Abstract] [Full Text] [Related]
11. Therapeutic equivalence of a generic slow-release theophylline tablet. Hendeles L, Breton AL, Beaty R, Harman E. Pharmacotherapy; 1995 Dec; 15(1):26-35. PubMed ID: 7739942 [Abstract] [Full Text] [Related]
12. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men. Dockhorn RJ, Cefali EA, Straughn AB. Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214 [Abstract] [Full Text] [Related]
13. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II. Ohmori N, Inotsume N, Matsukura M, Higashi A, Iwaoku R, Tobino Y, Nakano M, Matsuda I. Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632 [Abstract] [Full Text] [Related]
14. Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration. Steinijans VW, Sauter R, Böhm A, Staudinger H. Arzneimittelforschung; 1988 Aug; 38(8A):1241-50. PubMed ID: 3190813 [Abstract] [Full Text] [Related]
15. A single-dose, two-way crossover, bioequivalence study of dexmethylphenidate HCl with and without food in healthy subjects. Teo SK, Scheffler MR, Wu A, Stirling DI, Thomas SD, Stypinski D, Khetani VD. J Clin Pharmacol; 2004 Feb; 44(2):173-8. PubMed ID: 14747426 [Abstract] [Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677 [Abstract] [Full Text] [Related]
17. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration. Dulac O, Alvarez JC. Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218 [Abstract] [Full Text] [Related]
18. Absorption of theophylline from conventional and sustained-release tablets. Mellstrand T, Svedmyr N, Fagerström PO. Eur J Respir Dis Suppl; 1980 Jan; 109():54-60. PubMed ID: 6934088 [Abstract] [Full Text] [Related]
19. [The effect of food on theophylline absorption]. Pabst G, Weber W, Müller M, Barkworth MF. Arzneimittelforschung; 1998 May; 48(5A):569-73. PubMed ID: 9676346 [Abstract] [Full Text] [Related]
20. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers. Kapil R, Nolting A, Roy P, Fiske W, Benedek I, Abramowitz W. Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765 [Abstract] [Full Text] [Related] Page: [Next] [New Search]